Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy

Leendert van Steensel, P Martin van Hagen, Dion Paridaens, Robert W A M Kuijpers, Willem A van den Bosch, Hemmo A Drexhage, Herbert Hooijkaas, Willem A Dik

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy'. Together they form a unique fingerprint.

Medicine & Life Sciences